Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1277–1286. doi: 10.1517/17425255.2010.513970

Table 7.

Treatment regimen in a Phase III Non-inferiority trial

Treatment Regimen Phase-III non-inferiority trial
Arm 1 Day 1
150-mg IV Fosaprepitant
32-mg IV Ondansetron
12-mg PO Dexamethasone
Day 2
8-mg PO Dexamethasone
Day 3–4
16-mg PO Dexamethasone
Arm 2 Day 1
125-mg PO Aprepitant
32-mg IV Ondansetron
12-mg PO Dexamethasone
Cisplatin
Day 2–3
80-mg PO Aprepitant
8-mg PO Dexamethasone
Cisplatin
Day 4
8-mg PO Dexamethasone